Moonlake Immunotherapeutics - Class A (MLTX)'s 30-day implied volatility (IV30) was 87.0% at the close on October 22, 2026, up from 71.2% the day before, against a 52-week range of 48.8% to 195.7%. Its 20-day historical volatility was 56.1%.
Data as of October 22, 2026.